Skip to main content
Clinical Trials/NCT01171846
NCT01171846
Completed
Not Applicable

A Multicentre Randomised Controlled Trial of Pelvic Floor Muscle Training to Prevent Pelvic Organ Prolapse in Women

Glasgow Caledonian University3 sites in 2 countries337 target enrollmentAugust 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pelvic Organ Prolapse
Sponsor
Glasgow Caledonian University
Enrollment
337
Locations
3
Primary Endpoint
Pelvic organ prolapse symptom score (POP-SS)
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Pelvic organ prolapse is a problem experienced by women where a bulge comes down in the vagina, and may even drop down outside the vagina. The bulge in the vagina is caused by other organs moving down from their normal position in the pelvis and pushing into the vagina. This is a very common problem and many women who have given birth will have a very mild bulge which does not cause them symptoms. Women can however experience a variety of pelvic, bladder, bowel and sexual symptoms which impact on daily life. No research studies have properly examined whether or not exercises can prevent prolapse. This study aims to explore whether exercises taught by a physiotherapist can prevent women developing a prolapse which requires them to have treatment.

Registry
clinicaltrials.gov
Start Date
August 2010
End Date
December 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ms Suzanne Hagen

Programme Director

Glasgow Caledonian University

Eligibility Criteria

Inclusion Criteria

  • Women involved in the ProLong study who:
  • have some evidence of vaginal laxity in any compartment (POP-Q stage I, II or III)
  • have had no previous treatment for prolapse (surgery, pessary, PFMT)
  • Women must be willing to participate in the Trial and to comply with their group allocation.

Exclusion Criteria

  • with stage 0 or IV prolapse
  • who have had previous incontinence surgery (except mid-urethral sling operation)
  • who have had previous formal instruction in PFMT for any diagnosis in preceding five years
  • who are pregnant, or delivered a baby within the last six months
  • who are unable to comply with PFMT treatment
  • who are unable to give informed consent

Outcomes

Primary Outcomes

Pelvic organ prolapse symptom score (POP-SS)

Time Frame: 4 years post randomisation

A summation of responses to seven prolapse symptom questions (range 0-28)

Secondary Outcomes

  • Prolapse-related quality of life(4 years post of randomisation)
  • Prolapse severity(Four years post randomisation)
  • Lifestyle changes(4 years post randomisation)
  • Urinary symptoms(4 years post randomisation)
  • Bowel symptoms(4 years post randomisation)
  • Sexual symptoms(4 years post randomisation)
  • General health status(4 years post randomisation)
  • Need for prolapse treatment(4 years post randomisation)
  • The average number of days of prolapse symptoms(4 years post randomisation)

Study Sites (3)

Loading locations...

Similar Trials